16.00MMarket Cap-612P/E (TTM)
1.7600High1.6700Low65.23KVolume1.7200Open1.7600Pre Close110.60KTurnover1.36%Turnover RatioLossP/E (Static)9.47MShares3.550052wk High-0.54P/B8.10MFloat Cap1.050952wk Low--Dividend TTM4.79MShs Float143.4487Historical High--Div YieldTTM5.11%Amplitude1.0500Historical Low1.6950Avg Price1Lot Size
Trinity Biotech Stock Forum
📊⚡️📊
Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing Platform
Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor Technology
Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor Technology
DUBLIN, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced the successful completion of its first pre-pivotal clinical trial in Europe for its next-generation continuous glucos...
No comment yet